Charles Wood Ph.D. serves as program director (PD) with Rhonda Cooper-DeHoff, Pharm.D., M.S., and Eric Krause Ph.D., taking on the role of Co- PDs of this Institutional National Research Service Award (T32) titled: Multidisciplinary Training Program in Hypertension. As PD and co-PDs, Drs. Wood, Cooper-DeHoff, and Krause supervise the overall performance of the training program and consult with trainees, mentors, and staff as required.
Primary responsibility of the directors include:
- Organization of the annual retreat that is attended by all mentors and trainees as well as members of the internal and external advisory committees. During the retreat, the trainees supported by the T32 give formal presentation that provides an update on the progress of their research.
- Coordination of semi-annual progress report meetings attended by trainees, mentors and the internal advisory committee. Subsequently, the directors collect and analyze recommendations and provide this feedback to the trainees and mentors.
- Manage recruitment of potential trainees with local and national advertising of available positions. In conjunction with the internal advisory committee, the directors will evaluate the applicants, generate a list of applicants deemed appropriate for interview, and decide whom is invited to participate in the program.
Program Director: Charles E. Wood, Ph.D. is Professor and Chair of the Department of Physiology and Functional Genomics at the University of Florida. Dr. Wood is a recognized expert in cardiovascular development, and has published extensively on topics related to cardiovascular, endocrine, and renal development. Throughout his 34-year career as faculty at the University of Florida, Dr. Wood has trained 13 Ph.D. and 5 M.S. graduate students and 7 postdoctoral fellows, and currently has another 1 Ph.D. student and 3 M.S. students working towards graduation. In addition to these students, Dr. Wood has sponsored 10 M.D. or D.V.M. students in his laboratory. The Wood laboratory has been, for more than 3 decades, actively involved in research training of undergraduates (working towards course credit); there are typically 2-3 undergraduates working in this laboratory at any one time. Several undergraduates have graduated from U.F. with Honors after writing and filing an Honors thesis based on research completed in Dr. Wood’s laboratory. Dr. Wood has also served as the PI of a T35, then an R25 training grant for short-term training of minority undergraduate students in biomedical and cardiovascular research. Dr. Wood has served on NIH study sections and special emphasis panels, including one regular term on the Human Embryology and Development Subcommittee 1 study section. He has served as Chair of the Pregnancy and Neonatology (PN) study section. He is currently a regular member of the NHLBI Institutional Training Mechanism review group (NITM) and the American Heart Association (AHA) representative on the State of Florida Biomedical Research Advisory Council (advisory to the State of Florida Surgeon General). Dr. Wood has served as the Chair of the Research Committee of the Florida/Puerto Rico Affiliate of the AHA, and has been a member of the Board of Directors of that Affiliate. His service to the AHA throughout the years has included terms on peer-review panels, service on Research Committee, and on the steering committee that oversaw the peer review process in the Southern and Ohio Valley Research Consortium of the AHA. As the Chair of the Department of Physiology and Functional Genomics, it has been a high priority to create a high-quality environment for training of M.D., D.V.M., Pharm. D., and Ph.D. students that offers excellence in basic instruction in both medical and graduate courses and excellence in research training.
Program Co-Director: Rhonda Cooper-DeHoff, Pharm.D., M.S. is an Associate Professor of Pharmacotherapy and Translational Research and University Term Professor at the University of Florida. For the last three decades, Dr. Cooper-DeHoff’s research interests have included hypertension, metabolic syndrome, diabetes, coronary artery disease, as well as antihypertensive drug induced diabetes. Additionally, she has focused much of her research within these disease states / areas in understanding the impact of pharmacogenetic variations that impact these areas. She was the principal investigator for the NIH-funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs”, a co-investigator of the INternational VErapamil Trandolapril STudy (INVEST) which evaluated hypertension treatments in elderly coronary artery disease patients, and is MPI of the recently completed NHGRI PGRN grant Pharmacogenetics of Evaluation of Antihypertensive Responses (PEAR) grant – which includes genomics, transcriptomics and metabolomics data. She has complete data sets as well as clinical biobank samples available from all of these clinical trials, which are available to trainees to continue to generate new hypotheses and do discovery work in. Additionally, she has developed an adipocyte cell model in her laboratory to study the mechanisms associated with drug induced diabetes. Dr. Cooper-DeHoff is the director of the International Consortium for Antihypertensive Pharmacogenetic Studies (ICAPS) – which affords trainees the opportunity to collaborate at the international level; and she is the lead investigator of the hypertension working group within the PCORI funded Clinical Data Research Network (CDRN) OneFlorida – which affords trainees the opportunity to work at an epidemiologic level to explore population level questions with regard to hypertension and learn about the complexities and benefits of working in electronic health record data at the research level. Dr. Cooper-DeHoff is a highly regarded hypertension researcher and is very active in teaching clinician scientists.
Program Co-Director: Eric G. Krause, Ph.D. is an Associate Professor and University Term Professor in the Department of Pharmacodynamics at the University of Florida. Dr. Krause is an expert in the neural control of hydromineral balance and cardiovascular function. Since starting his career in biomedical research in the Summer of 2000 he has published >50 peer-reviewed articles in this area, has given numerous invited lectures, and his research has been continuously supported by the National Institutes of Health (NIH). It is worth noting that Dr. Krause followed the career path laid out by the NIH. Initially, his graduate studies were supported by a minority supplement to a T32, which allotted him the independence to write and successfully obtain individual pre-doctoral (F31) and post-doctoral (F32) National Research Service Awards. Subsequently, Dr. Krause was among the early cohort of trainees given the NIH Pathway to Independence Award (K99/R00). Dr. Krause has graduated 2 Ph.D. students and currently mentors 2 undergraduate students, 1 Ph.D. student, 2 postdoctoral fellows, and 1 visiting scholar. In addition, Dr. Krause actively serves as a mentor for the R25 short-term training program for minority undergraduate students in biomedical and cardiovascular research as well as the College of Pharmacy summer research internship program. In total, he has mentored 8 students through participation in these programs. Dr. Krause is on the editorial board for Physiological Genomics and Physiology & Behavior and served on study sections for the Netherlands Organization for Scientific Research, Israel Science Foundation, and the American Heart Association. Dr. Krause considers mentoring an important part of his professional life and moving forward will direct much of his effort towards fostering excellence in training for hypertension research.